Shares of Nemetschek SE declined over 5% in Monday trading, reaching an intraday low of 555.10, after UBS downgraded the German construction software group to "sell" from "neutral" and reduced its 12-month price target to 56 from 76. The bank's reassessment centers on the risk that multi-year subscription contracts - previously a contributor to growth - could become a headwind for the company.
The stock has retreated sharply from its peak of 137.70 over the past 52 weeks, losing more than half of that value, and is down from 90.30 at the start of 2026. Monday's trading session volume of 235,760 shares was reported as surpassing the average daily volume of 275,000 shares.
UBS's analysis quantifies the contribution of multi-year deals to Nemetschek's Design segment in 2025. The bank estimated these contracts added about 19 million in revenue, equivalent to nearly 400 basis points of incremental Design growth. However, the structure of those deals produces most revenue in year one: the contracts generated 43 million in their first year but are expected to yield just 13 million in year two. UBS calculated that this dynamic will create roughly a 30 million year-on-year revenue headwind - more than 500 basis points for the Design division.
"The growth impact of the multi-year contracts for Design in Q4, that will be approximately slightly south of 4 percentage points out of the 6.5%," management said on the Q4 2025 results call, as cited in the report.
Reflecting the anticipated drag, UBS cut its Design growth forecast for 2026 to 5% from 9%, and trimmed the 2027 projection to 6% from 8%. Those reductions pull UBS's view of Nemetschek's group organic growth to 12%, below the company's own target range of 14-15%. At the group level, UBS lowered 2026-2028 earnings per share estimates by 4-5%, leaving its forecasts 2-11% beneath consensus estimates.
On the balance-sheet front, Nemetschek reported remaining performance obligations of 69.5 million at the end of 2025, up from 41.8 million at the end of 2024. The company also carried 30.7 million in long-term deferred revenue. Capitalised costs to obtain contracts rose to 44.7 million from 17.9 million over the same period, which UBS used to imply gross multi-year contract additions of approximately 143 million in 2025 based on an assumed 28% commission rate.
The company's chief financial officer commented on the full-year 2025 results call that management did not expect "an additional tailwind to multi-year contracts in 2026," and warned that the contract asset balance was likely to "increase in 2026 we estimate somewhere around half of the book value of this, so around the mid-teens."
For valuation, UBS employed an equally weighted blend of two approaches. One leg uses a 2027 EV/EBITDA multiple of 11.4x, removing Nemetschek's historical 40% premium to peers. The other is a discounted cash flow model assuming 8% medium-term growth and a 25% EBITDA margin, which produced a DCF-derived value of 65.60. Combining those methods led UBS to lower its price target to 56.
UBS's return expectation for Nemetschek was a negative 7.5% total return, comprising an 8.6% decline in price partly offset by a 1.1% dividend yield, measured against the bank's market return assumption of 7.6%.
Context and market reaction - The UBS downgrade and accompanying note emphasizing the changing economics of multi-year subscriptions precipitated the share price weakness. The bank's adjusted growth and earnings assumptions, together with a valuation that removes a historical premium to peers, underpin the new sell rating and reduced price target.
What remains clear from the disclosures is the company's exposure to timing effects from subscription accounting and contract structures; that exposure is driving both UBS's forecast changes and the market's immediate response.